• Explore /
  • Poster
  • / A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation.

A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation.

Abstract Poster

Authors

null

Doris M. Ponce

Memorial Sloan Kettering Cancer Center, New York, NY

Doris M. Ponce , Satyajit Kosuri , Nandita Khera , Zachariah Michael DeFilipp , Mary-Jane Lombardo , Christopher B. Ford , Jonathan U. Peled , Marcel R. M. Van Den Brink , Lisa von Moltke , Bindu Tejura

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant

Track

Hematologic Malignancies

Sub Track

Allogenic Stem Cell Transplantation

Clinical Trial Registration Number

NCT04995653

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS7080)

DOI

10.1200/JCO.2023.41.16_suppl.TPS7080

Abstract #

TPS7080

Poster Bd #

206b

Abstract Disclosures

Similar Posters

First Author: Doris M. Ponce

First Author: Alla Paskovaty

First Author: Krish Patel

First Author: Guilhem Roubaud